Heteroresistance to Piperacillin-Tazobactam in Clinical Isolates of Escherichia coli Sequence Type 131

Antimicrob Agents Chemother. 2017 Dec 21;62(1):e01923-17. doi: 10.1128/AAC.01923-17. Print 2018 Jan.

¹ Clinical Unit of Infectious Diseases, Microbiology and Preventive Medicine, Institute of Biomedicine of Seville (IBiS), University Hospital Virgen del Rocío/CSIC/University of Seville, Seville, Spain.
² Department of Medicine, University of Seville, Seville, Spain.
³ Department of Microbiology, University of Seville, Seville, Spain.
⁴ Clinical Unit of Infectious Diseases, Microbiology and Preventive Medicine, Institute of Biomedicine of Seville (IBiS), University Hospital Virgen del Rocío/CSIC/University of Seville, Seville, Spain ysmani-ibis@us.es.

No abstract available

Keywords: Escherichia coli; ST131; heteroresistance; piperacillin-tazobactam.

Publication types